B. Braun Medical To Invest $1 Billion to Expand IV Therapy Mfg

By Patricia Van Arnum - DCAT Editorial Director

May 16, 2019

B. Braun Medical, which develops, manufactures, and markets products for infusion therapy and pain management, has announced a $1-billion investment in new and enhanced IV therapy manufacturing facilities. The investments include a new manufacturing facility in Daytona Beach, Florida and modernization to existing facilities in Irvine, California, and Allentown, Pennsylvania.

The company says that the investment is meant to address on industry-level nationwide IV fluid shortages that have resulted over recent years to due destructive weather events, such the hurricanes in Puerto Rico, and severe influenza seasons.

As part of its $1-billion investment, the company will expand capacity of IV fluid production at two large-scale IV fluid production facilities  through a new manufacturing facility in Daytona Beach, Florida and modernization of its existing manufacturing facility in Irvine, California. It will also expand its IV therapy-device manufacturing facility in Allentown, Pennsylvania. It is also planning a new distribution facility in Daytona Beach and making enhancements to existing distribution facilities in Ontario, California and Breinigsville, Pennsylvania.

B. Braun has also obtained US Food and Drug Administration approval of IV fluids from European facilities should the need arise in the future. Several years ago, B. Braun prioritized and began investments to support long-term and ongoing supply capacity. Discussions with hospitals, policymakers, supply-chain leaders and healthcare providers following Hurricane Maria in 2017 further cemented the company’s expansion plans, said the company.

Source: B. Braun Medical